NHS England’s cancer waiting times for Bradford Teaching Hospitals NHS Foundation Trust (provider code RAE), August 2026 (provisional). Figures are provider-based, as NHS England publishes them.
August 2026 is provisional. NHS England says: “Monthly data are released as provisional data and subsequently finalised in line with the NHS England revisions policy.” These figures can therefore change when NHS England revises them, and Docorix updates them when it does. Source: NHS England, Cancer Waiting Times, August 2026 (provisional), “Monthly Combined CSV”, released 8 October 2026. Imported by Docorix on 31 October 2026. Contains public sector information licensed under the Open Government Licence v3.0. Information from NHS England. Source pages last checked 31 October 2026.
As NHS England publishes them; “–” means fewer than 20 patients. Cancer types are grouped more coarsely from October 2023 than before, and the Faster Diagnosis Standard uses its own “suspected cancer” groups. “(a)” after a name is NHS England’s own footnote marker in the file.
| Suspected cancer type | Patients | Within the standard | England |
|---|---|---|---|
| Exhibited (non-cancer) breast symptoms - cancer not initially suspected | 139 | 100.0% | 89.8% |
| Suspected breast cancer | 211 | 91.9% | 87.9% |
| Suspected cancer - non-specific symptoms | 11 | – | 76.0% |
| Suspected children's cancer | 5 | – | 89.3% |
| Suspected gynaecological cancer | 105 | 82.9% | 68.7% |
| Suspected haematological malignancies (excluding acute leukaemia) | 10 | – | 62.1% |
| Suspected head & neck cancer | 221 | 67.9% | 76.1% |
| Suspected lower gastrointestinal cancer | 251 | 81.3% | 68.0% |
| Suspected lung cancer | 42 | 88.1% | 77.7% |
| Suspected skin cancer | 503 | 67.0% | 85.8% |
| Suspected testicular cancer | 9 | – | 85.3% |
| Suspected upper gastrointestinal cancer | 141 | 91.5% | 78.0% |
| Suspected urological malignancies (excluding testicular) | 115 | 73.0% | 67.7% |
| Cancer type | Patients | Within the standard | England |
|---|---|---|---|
| Breast | 72 | 97.2% | 91.3% |
| Gynaecological | 14 | – | 92.3% |
| Haematological - Lymphoma | 4 | – | 98.3% |
| Haematological - Other (a) | 7 | – | 99.2% |
| Head & Neck | 16 | – | 91.9% |
| Lower Gastrointestinal | 20 | 90.0% | 93.5% |
| Lung | 5 | – | 93.5% |
| Skin | 54 | 94.4% | 87.3% |
| Upper Gastrointestinal - Hepatobiliary | 9 | – | 96.2% |
| Upper Gastrointestinal - Oesophagus & Stomach | 9 | – | 97.3% |
| Urological - Other (a) | 14 | – | 87.4% |
| Urological - Prostate | 35 | 100.0% | 92.2% |
| Cancer type | Patients | Within the standard | England |
|---|---|---|---|
| Breast | 39 | 67.9% | 70.5% |
| Gynaecological | 8.5 | – | 61.2% |
| Haematological - Lymphoma | 1.5 | – | 67.9% |
| Haematological - Other (a) | 4 | – | 90.3% |
| Head & Neck | 8.5 | – | 60.3% |
| Lower Gastrointestinal | 10 | – | 62.4% |
| Lung | 9.5 | – | 62.0% |
| Other (a) | 1.5 | – | 81.3% |
| Skin | 35 | 77.1% | 87.0% |
| Upper Gastrointestinal - Hepatobiliary | 3 | – | 79.1% |
| Upper Gastrointestinal - Oesophagus & Stomach | 5 | – | 70.1% |
| Urological - Other (a) | 10.5 | – | 60.9% |
| Urological - Prostate | 24.5 | 75.5% | 71.0% |
Waiting times for hospital treatment at this provider All providers
Wording from NHS England’s Cancer Waiting Times statistical release (PDF), August 2026.
August 2026 is provisional. NHS England says: “Monthly data are released as provisional data and subsequently finalised in line with the NHS England revisions policy.” These figures can therefore change when NHS England revises them, and Docorix updates them when it does.
“Within the standard” counts patients who met it. Providers differ in size and in the cancers they treat, so Docorix lists them A to Z and does not rank them. Counts in NHS England’s file can include halves. NHS England’s release lists any provider that did not submit, or submitted only part of its data, in an annex; check it before drawing conclusions about a single provider (monthly statistics page).
Cancer types for the 31-day and 62-day standards are grouped more coarsely from October 2023 than before, and the Faster Diagnosis Standard uses its own “suspected cancer” groups, so the type tables on provider pages are not directly comparable with figures from before October 2023.
Docorix is not part of the NHS. This page is information, not medical advice. If you are worried about symptoms, contact your GP or NHS 111.